Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2003
06/05/2003US20030106085 Disruption of the prostaglandin E synthase 2 gene
06/05/2003US20030106084 Heat resistant antigen/cd24 fusion proteins; immunoglobulins; autoimmune disorders
06/05/2003US20030106080 PTTG knockout rodent as a model to study mechanisms for various physiological phenomena, including diabetes
06/05/2003US20030106078 mcFP encoding nucleic acids, polypepetides, antibodies and mehods of use thereof
06/05/2003US20030106076 Methods for identifying genes expressed in selected lineages, and a novel genes identified using the methods
06/05/2003US20030106075 Novel gene encoding organic anion transporter
06/05/2003US20030106073 Formylpeptide chemoattractant receptors(fpr-rs4); g-protein coupled receptors; antiepileptic agents
06/05/2003US20030105593 Selection of target segments within target genes using a correspondence regime between different triplets of three bases and the three possible positions of a triplet within a nine-base site; A computer program product
06/05/2003US20030105319 Bacillus endotoxin for controlling moths; cry proteins
06/05/2003US20030105318 G-protein transmembrane domain; protein synthesis inhibitor; neurotransmitter
06/05/2003US20030105317 DNA encoding orphan SNORF65 receptor
06/05/2003US20030105316 Regulation of human opsin-related g protein-coupled receptor
06/05/2003US20030105315 Cancer diagnosis; antitumor agents; antiproliferative agents; gene transfer agents
06/05/2003US20030105312 Antitumor agents; autoimmune disease and cancer diagnosis; antiproliferative agents
06/05/2003US20030105307 Streptococcus pneumoniale 37-kDa surface adhesion a protein
06/05/2003US20030105304 Metal binding proteins and associated methods
06/05/2003US20030105303 Primate phagocytic leukocyte protein; detection and diagnosis of immunological disorders; cancer detection
06/05/2003US20030105302 Fibroblast cell growth factor; for diagnosis, detection and prevention of skin, cancer, brain, glandular, cell differentiation/ proliferative and placental disorders; antiproliferative agents, antitumor agents
06/05/2003US20030105298 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030105297 Antibody; for diagnosis of bone, nervous system, blood, autoimmune and cancer disorders
06/05/2003US20030105296 Mammalian cytokine-like factor 7
06/05/2003US20030105295 Antagonists of interleukin-15
06/05/2003US20030105293 Human circulating cytokine cc-1
06/05/2003US20030105292 Continously induced g-protein coupled receptors; membrane binding assays
06/05/2003US20030105291 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030105290 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030105289 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030105288 Membrane proteins; antitumor agents; antiproliferative agents; tumor necrosis factor
06/05/2003US20030105287 Inhibition of the proliferation of cells of the multiple myeloma
06/05/2003US20030105286 Comprises pseudo-isocytosine and pseudo-uracil for increasing binding affinity to DNA/RNA strands
06/05/2003US20030105285 Odorant receptors
06/05/2003US20030105284 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
06/05/2003US20030105283 Antigenic protein originating in malassezia
06/05/2003US20030105282 Reduced binding affinity for cd4-antigen; immunoassays: vaccines
06/05/2003US20030105281 Piscidides: antibiotic resistance
06/05/2003US20030105277 Tat transport proteins; antiproliferative agents; antitumor agents
06/05/2003US20030105224 Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith
06/05/2003US20030105166 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
06/05/2003US20030105165 Gap junctions and EDHF
06/05/2003US20030105058 CD44-like protein
06/05/2003US20030105054 For eliciting an immune response and enhancing current therapeutic modalities for the treatment of cancer; stimulates T cell proliferation
06/05/2003US20030105049 For use in diagnosis and therapy
06/05/2003US20030105045 Artificial transcriptional factors and methods of use
06/05/2003US20030105039 Introducing into eukaryotic cell recombinase and single-stranded targeting polynucleotides which are complementary and each having a homology clamp that corresponds to or is complementary to preselected target DNA
06/05/2003US20030105024 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
06/05/2003US20030105021 Using peptide comprising a chain of 7 to 17 contiguous amino acids derived from region of human TNF- alpha from Ser100 to Glu116 or from region of mouse TNF- alpha from Ser99 to Glu115 for manufacture of a medicament for oedema
06/05/2003US20030105019 Tumor endothelial marker 5alpha molecules and uses thereof
06/05/2003US20030105017 Protecting free sulfhydryl groups of Troponin I under reducing conditions
06/05/2003US20030105015 Promoting growth of bone, ligament, or cartilage in a mammal by administering zvgef4 (endothelial growth factor) in delivery vehicle
06/05/2003US20030105014 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor
06/05/2003US20030105013 For therapy of wounds, various cancers, and disorders of the vessels including atherosclerosis and cardiac hypertrophy
06/05/2003US20030105012 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
06/05/2003US20030105011 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
06/05/2003US20030105010 Obtaining three-dimensional structural coordinates defining protein or binding pocket of protein, from crystal of protein; introducing structural coordinates into a computer to produce database containing molecular structural coordinates
06/05/2003US20030105009 Polypeptides of covalently linked synthetic bioactive peptide analog(s) for treatment of cancer
06/05/2003US20030105008 Geminin and Orc3N inhibit replication of herpesviruses, papillomaviruses, and polyomaviruses
06/05/2003US20030105007 PDGF-betabeta and fibronectin combined in a solid wound dressing for the treatment of wounds
06/05/2003US20030105006 For therapy of bacterial infections
06/05/2003US20030105004 Novel morphogenic protein compositions of matter
06/05/2003US20030105003 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
06/05/2003US20030105002 RGS compositions and therapeutic and diagnostic uses therefor
06/05/2003US20030105001 Pro-apoptotic proteins and DNA molecules encoding them
06/05/2003US20030105000 Methods and compositions for inhibiting GRB7
06/05/2003US20030104998 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104993 Promoting survival of neurons or nerve cells, stimulating cell differentiation, detecting and monitoring neuropathies; a biocompatible tubular casing having openings adapted to receive the ends of a severed nerve, promoting healing
06/05/2003US20030104987 Methods of using the hyaluronan receptor for endocytosis
06/05/2003US20030104984 Inhibitor of stem cell proliferation and uses thereof
06/05/2003US20030104981 A mutant amino acid sequence for treating diabetes, comprising replacement, substitution of an amino acid with increasing resistance to insulin-degrading enzyme; enzyme resistance
06/05/2003US20030104978 A polypeptide encoded by nucleic acid constructs; recombinant host cell, transgenic animal, transgenic plant; treating blood bleeding, hemostasis
06/05/2003US20030104977 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
06/05/2003US20030104973 Purified, isolated and cloned nucleic acid polynucleotide encoding hypoxia-regulating genes and the proteins and antibodies specifically bind these proteins; genetic engineering
06/05/2003US20030104970 Modulating the growth state of an epithelial cell by ectopically contacting the epithelial cell, in vitro or in vivo, with hedgehog polypeptide or patched therapeutic to promote or inhibit of proliferation of epithelial cell
06/05/2003US20030104626 Packaging systems for human recombinant adenovirus to be used in gene therapy
06/05/2003US20030104624 Novel vector constructs
06/05/2003US20030104621 Method of expressing genes in mammalian cells
06/05/2003US20030104620 Expression vector for expression of heterologous polypeptides and amplification of cell viral resistance; viricides
06/05/2003US20030104619 Hypoxia-mediated neurogenesis
06/05/2003US20030104611 Feline immunodeficiency virus gene therapy vectors
06/05/2003US20030104607 Expression of a human insulin precursor in P. pastoris
06/05/2003US20030104606 Biosensor for detection of vibrio luminescent protein; biological pest control; bactericides; gene expression inhibition
06/05/2003US20030104602 Adipocyte complement related protein zacrp3X2
06/05/2003US20030104601 Chondroitin synthase gene and methods of making and using same
06/05/2003US20030104599 Polypeptide (suv39h2) having histone methyltransferase activity; antitumor agents; meiotic chromatin; contraceptives
06/05/2003US20030104589 Tissue adhesive using synthetic crosslinking
06/05/2003US20030104581 Biosynthesis and recovery of viricides from prokaryotic cells
06/05/2003US20030104580 Method for producing proteins
06/05/2003US20030104579 Pluripotent stem cells; antitumor agents; antiproliferative agents; antiinflammatory agents; veterinary medicine; tissue engineering
06/05/2003US20030104578 Secreted in yeast; storage stability; microbiocides
06/05/2003US20030104577 Gag genes and gag protein; cell-free translation; transcriptases; viricides; enzyme inhibitors
06/05/2003US20030104574 Mutant cell lines and methods for producing enhanced levels of recombinant proteins
06/05/2003US20030104573 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis
06/05/2003US20030104572 Nucleic acid molecules encoding kappa3, opioid receptors, receptors encoded thereby, and uses thereof
06/05/2003US20030104571 Flexible method and apparatus for high throughput production and purification of multiple proteins
06/05/2003US20030104570 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest
06/05/2003US20030104569 Proteins suppressing proliferation of lympho-hematopoietic cells
06/05/2003US20030104567 Receptor based antagonists and methods of making and using
06/05/2003US20030104566 Membrane proteins; tumor diagnosis; antiproliferative agents; antitumor agents; antisense agents; neovascularization
06/05/2003US20030104565 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104564 Membrane proteins; tumor diagnosis; antiproliferative agents; antitumor agents; antisense agents; neovascularization
06/05/2003US20030104563 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 ... 2916